COMP <GO>
ADUS vs ABBV // NET PROFIT MARGIN
Addus HomeCare Corporation (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: ADUS 7
— ABBV 6
▲ NET PROFIT MARGIN LEADER: ABBV
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
net-margins
6.70%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
net-margins
6.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 70.20% | -37.70 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | 29.00% | -19.90 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.8x | 33.3x | -16.50 | ADUS | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 3.47% | +1.00 | ADUS | /fcf-yield <GO> |
| Operating Margin | 9.70% | 24.60% | -14.90 | ABBV | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 6.70% | 6.90% | -0.20 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | 8.60% | +14.60 | ADUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 5.33 | +0.50 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.1 | 65.1 | +8.01 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | 113.1x | -92.80 | ADUS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $513.86B | -$511.54B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | ABBV REV | ADUS GROSS % | ABBV GROSS % | ADUS FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $61.16B | 32.5% | 70.2% | $103.8M | $17.82B |
| FY 2024 | $1.15B | $56.33B | 32.5% | 70.0% | $110.4M | $17.83B |
| FY 2023 | $1.06B | $54.32B | — | — | $112.2M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
ABBV // BETA 1.15